Red Propolis Supplementation as a Strategy in Chronic Kidney Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversidade Federal Fluminense
About this trial
The objective of this study is to evaluate the effects of red propolis on inflammation and oxidative stress in patients with chronic kidney disease on conservative management.
Eligibility criteria
Qualifiers
patients with CKD stages 3-5 under conservative management
Disqualifiers
pregnant,
lactating,
smoker
patients using antibiotics and antioxidant supplements in the last three months
Trial design
Treatments tested in this trial
- Red Propolis
- Placebo Control
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov